Appointments

What to bring to a menopause appointment

The appointment is short and the history is long. Preparation is the difference between a consultation that moves things forward and one that ends with "let us see how you get on".

By HRT AI — see our editorial standards Published Last reviewed 9 min read

The short answer

Bring five things: a dated symptom summary with numbers rather than adjectives; your current regimen exactly as you actually take it, including missed doses; a full medication and supplement list; the personal and family history that affects risk assessment; and your top two priorities written down.

Two priorities, not eight. A ten-minute appointment can properly address two things. Deciding in advance which two matter most is the single highest-value thing you can do beforehand — otherwise the agenda gets set by whichever symptom you happen to mention first.

Why preparation changes the outcome

For most people over 45, menopause is diagnosed from symptoms rather than a blood test — NICE guideline NG23 is explicit that perimenopause and menopause should be identified in women aged over 45 without laboratory tests. Your account of your symptoms is the evidence. If that account is vague, the assessment it supports is vague.

The same guidance frames the treatment conversation as shared decision-making: the clinician sets out benefits and risks in the context of your history, and you decide together. Shared decisions need two informed parties. Turning up with dates, numbers, and two clear priorities is what makes you the second one.

1. A dated symptom summary, in numbers

The most common failure is answering "how are the symptoms?" with "not great". It is honest and it is unusable. Replace adjectives with counts wherever you can:

Include the comparison. The same figures from a month or three months ago turn a snapshot into a direction, and direction is usually what determines whether anything changes. Improving, static, and worsening lead to three different conversations.

2. Your regimen as you actually take it

Not what is on the prescription — what actually happens. These are different for most people, and the gap between them is diagnostic information rather than a confession:

Different routes fail in different, predictable ways — see estradiol delivery routes and what changes about tracking each. Naming the failure mode out loud is often more productive than reporting the symptom it caused.

3. Medications, supplements, and the history that affects risk

Risk assessment for hormone therapy is individual, and it depends on facts a clinician cannot guess. Have these to hand:

Everything else you take

Prescription medicines, over-the-counter medicines, herbal products and supplements. Some interact with hormone therapy or with each other; several herbal products marketed for menopause have documented interactions. "Nothing, just a few supplements" is the answer that causes problems.

Your own medical history

Blood clots, stroke, heart disease, migraine (and whether with aura), high blood pressure, liver disease, diabetes, breast or gynaecological cancer, gallbladder disease, and whether you still have a uterus and ovaries. Surgical history matters: an oophorectomy changes the picture entirely.

Family history

Breast, ovarian and endometrial cancer, and venous thromboembolism, in first-degree relatives, with ages at diagnosis where you know them. Ages matter as much as the diagnosis.

Screening status

When you last had cervical screening, a mammogram where applicable, a blood pressure reading, and any bone-density scan. Being able to say "last month" or "four years ago" saves a chunk of the appointment.

4. Your two priorities, written down

This is the part people skip and the part that most changes the appointment. Symptom lists are long. Ten minutes is short. If you do not choose, the agenda is set by chance — usually the first thing you mention, which is often not the thing wrecking your life.

So decide beforehand, and be concrete about the outcome you want. Not "the sleep" but "I want to stop waking at 3am four nights a week." Not "I feel awful" but "the brain fog is affecting my work and I want to know whether that is likely to be part of this." A specific target gives the clinician something to aim at, and gives you a way to tell at the next visit whether anything worked.

Write both at the top of your notes. Say them in the first minute.

5. Questions worth asking

Adapt these to your situation. The point is to leave with a plan you understand rather than a prescription you do not.

  1. Based on my history, what are the specific benefits and risks for me — not the population average?
  2. What are the options here, including the non-hormonal ones? NICE guidance covers non-hormonal approaches including cognitive behavioural therapy for vasomotor symptoms and for low mood arising in this context.
  3. How long before we would expect to know whether this is working, and what will we measure?
  4. What would make you change or stop this?
  5. Which side effects are expected and settle, and which mean I should contact you?
  6. Do I need a progestogen for endometrial protection, and why or why not in my case?
  7. Are my genitourinary symptoms being treated separately? Local vaginal treatment is a distinct question from systemic therapy.
  8. When is the review, and what should I bring to it?
  9. If this does not work, what is the next option?

Write the answers down during the appointment, or immediately after. Post-appointment recall is poor, and a plan you cannot reconstruct is not a plan.

If you feel dismissed

It happens, and it is not evenly distributed — people with early menopause, premature ovarian insufficiency, surgical menopause, and those on gender-affirming hormone therapy all report having to argue harder to be assessed properly. A few things that help without turning the appointment adversarial:

The shortcut

All of the above is one page of paper. If you keep a running log, most of it is already written and the preparation is just reading it back. That is what the HRT AI clinician report is for — one tap produces a single-page PDF containing:

So the numbers are worked out before you sit down. The weekly summary also ends with something worth raising next time, which tends to be where the two priorities come from — and where a symptom pattern crosses a threshold worth mentioning, the app files it as a question for the appointment rather than telling you what it means.

HRT AI one-page clinician report showing current regimen, hot flash trend, symptom averages and questions for the visit
The clinician report
HRT AI weekly insight screen naming what changed and one question for the next appointment
One question to bring

Common questions

How far back should my symptom summary go?

Two weeks of recent detail plus one comparable earlier stretch — a month or three months back — is enough. Direction over time is more useful than volume of entries.

Should I bring my whole diary or a summary?

A summary, with the full record available if asked. Ninety pages of daily entries will not be read inside a short appointment, and the useful content gets lost in them.

Do I need a blood test before the appointment?

Not usually, if you are over 45. NICE guideline NG23 says perimenopause and menopause should be diagnosed in women over 45 on symptoms alone, and sets out a narrower role for FSH testing between 40 and 45, or under 40 where premature ovarian insufficiency is suspected. Your clinician may order tests for other reasons, such as ruling out thyroid disease.

What if my appointment is only ten minutes?

Then two priorities is the honest ceiling, and preparing them is what makes ten minutes enough. Say them in the first minute, hand over the summary, and ask when the review is. A second appointment for the rest is a better outcome than eight items covered badly.

Is it worth asking about non-hormonal options?

Yes. NICE guidance covers non-hormonal approaches, including cognitive behavioural therapy for vasomotor symptoms and for low mood or anxiety arising in this context, and professional bodies have published position statements on nonhormone management. Whether any of it suits you is a clinical conversation, but it is a legitimate question to put on the table.

Sources

  1. National Institute for Health and Care Excellence. Menopause: identification and management (NG23) — diagnosis over 45 without laboratory tests; role of FSH testing; shared decision-making; non-hormonal options including CBT.
  2. NHS. Menopause and perimenopause — treatment
  3. American College of Obstetricians and Gynecologists. Clinical guidance on management of menopausal symptoms
  4. The Menopause Society. Position statements on hormone and nonhormone therapy
  5. British Menopause Society. Tools for clinicians and patient information sheets

Walk in with the numbers already worked out.

HRT AI turns months of check-ins into a one-page report you can hand over.

Download on the App Store